Publications

21.02.26

Open Systems Pharmacology Community Conference (OSP-CC) Proceedings 2025

ConferenceDDIJournalMethodologyPBPK/PBBMRegulatory interactionsSpecial/specific populationsTrial design and analysis

CPT Pharmacometrics Syst Pharmacol. 2026 Mar;15(3):e70217. Online ahead of print

Cordes H, Annaert P, Balazki P, Benamara S, Bonan RH, Butler A, Chenel M, Cui Y, Dallmann A, de Witte WEA, Demeester C, Feick D, Gattacceca F, Geci R, Gerebtzoff G, Gruber A, Guimarães M, Hamadeh A, Hanke N, Ibarra M, Ince I, Kanacher T, Kuepfer L, Mil F, Montaseri G, Nauwelaerts N, Proenca S, Schaller S, Schlender JF, Schneider ARP, Sjögren E, Solodenko J, Staab A, Vrenken P, Troisi C, Teutonico D..

28.01.26

Conditional versus unconditional covariate effects in pharmacometric models: implications for interpretation, communication, and reporting

JournalMethodologyPharmacometricsRegulatory interactions

CPT Pharmacometrics Syst Pharmacol. 2026 Feb;15(2):e70203.

Jonsson EN, Jönsson S, Hansson E, Nyberg J.

09.01.26

Risks encountered when not adjusting for diurnal variation and food effect in QTcF analysis based on Phase I data

JournalMethodologyMIDDPharmacometrics

J Pharmacokinet Pharmacodyn. 2026 Feb;53(1):6.

Bardol M, Sarr C, Henrich A, Mezzalana E, Langenhorst J.

22.12.25

Prediction of Monoclonal Antibodies Pharmacokinetics in Human: Identification of a Reference Neonatal Fc Receptor (FcRn) Binding Affinity Using Physiologically Based Pharmacokinetic (PBPK) Modeling

JournalPBPK/PBBMProgram strategies and efficiencies

ACS Pharmacol. Transl. Sci. 2025 Dec 22. Online ahead of print.

Benamara S, Sjögren E, Gattacceca F, Chenel M, Deslandes A, Nguyen L, Teutonico D.

09.12.25

Population Pharmacokinetics and Exposure‐Response Model‐Based Bayesian Extrapolation of FVC‐Based Efficacy Endpoints From Adults to Pediatric Patients Receiving Nintedanib

JournalMethodologyMIDDPharmacometricsProgram strategies and efficienciesRegulatory interactionsRespiratorySpecial considerationsSpecial/specific populations

CPT Pharmacometrics Syst Pharmacol. 2025 Dec 9. Online ahead of print.

Hartman S, Chan Kwong A, Ribbing J, Gahlemann M, Korell J.

Below we provide links to posters, white papers and scientific publications by Pharmetheus affiliates in chronological order. Please note that access to some publications may require a subscription.

Featured Publications

Risks encountered when not adjusting for diurnal variation and food effect in QTcF analysis based on Phase I data

Exposure-response analysis for time-to-event data in the presence of adaptive dosing: efficient approaches and pitfalls

Population Pharmacokinetics and Exposure‐Response Model‐Based Bayesian Extrapolation of FVC‐Based Efficacy Endpoints From Adults to Pediatric Patients Receiving Nintedanib

Search Publications

Publications 5 of 235

Featured Publications

Risks encountered when not adjusting for diurnal variation and food effect in QTcF analysis based on Phase I data

Exposure-response analysis for time-to-event data in the presence of adaptive dosing: efficient approaches and pitfalls

Population Pharmacokinetics and Exposure‐Response Model‐Based Bayesian Extrapolation of FVC‐Based Efficacy Endpoints From Adults to Pediatric Patients Receiving Nintedanib

Search Publications

Publications 5 of 235

Related content

Science and Services

Case studies

Scientific Publication